Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian heart Rhythm Society

This item appears in the following Collection(s)

Search NSF DL


Advanced Search

We Want your Feedback

Browse

My Account

Quick Links